{"protocolSection":{"identificationModule":{"nctId":"NCT04297358","orgStudyIdInfo":{"id":"2017-02131"},"organization":{"fullName":"Hyperbaric Center Basel","class":"OTHER"},"briefTitle":"Hyperbaric Oxygen in Patients Who Had a Stroke","officialTitle":"Hyperbaric Oxygen Treatment in Chronic Stroke a Feasibility Study","acronym":"HOST"},"statusModule":{"statusVerifiedDate":"2023-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2017-12-20","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-12-30","type":"ACTUAL"},"completionDateStruct":{"date":"2022-12-31","type":"ACTUAL"},"studyFirstSubmitDate":"2020-02-26","studyFirstSubmitQcDate":"2020-03-03","studyFirstPostDateStruct":{"date":"2020-03-05","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-03-01","lastUpdatePostDateStruct":{"date":"2023-03-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Hyperbaric Center Basel","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"Prospective clinical assessment of 40 Hyperbaric Oxygen (HBO) treatments in 10 completed stroke patients.","detailedDescription":"10 patients having suffered a stroke and having being rehabilitated will be treated with 40 consecutive Hyperbaric Oxygen Treatment (HBOT) after a minimal delay of 3 months after stroke. They will be neurologically assessed before and 3 months after HBOT. Rivermead mobility index will be also assessed."},"conditionsModule":{"conditions":["Stroke","Hyperbaric Oxygen"],"keywords":["Hyperbaric Oxygen","Completed Stroke","Feasibility","Prospective"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":10,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Stroke patients","type":"EXPERIMENTAL","description":"40 consecutive sessions of hyperbaric oxygen will be administered at a pressure of 2 absolute atmosphere (ATA) to 10 patients. If there are drop outs, recruitment will be continued until a total of 10 patients with at least 30 sessions.","interventionNames":["Drug: Hyperbaric oxygen"]}],"interventions":[{"type":"DRUG","name":"Hyperbaric oxygen","description":"40 consecutive (5/7) sessions of hyperbaric oxygen","armGroupLabels":["Stroke patients"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change in National Institutes of Health Stroke Scale (NIHSS score)","description":"Neurological assessment before and after HBOT. Composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0 (0 is better).","timeFrame":"Change from Baseline NIHSS Score at 3 months"},{"measure":"Change in Rivermead mobility index (RMI) at 2 weeks","description":"Mobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.","timeFrame":"Change from Baseline RMI at 2 weeks"},{"measure":"Change in Rivermead mobility index (RMI) at 4 weeks","description":"Mobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.","timeFrame":"Change from Baseline RMI at 4 weeks"},{"measure":"Change in Rivermead mobility index (RMI) at 6 weeks","description":"Mobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.","timeFrame":"Change from Baseline RMI at 6 weeks"},{"measure":"Change in Rivermead mobility index (RMI) at 8 weeks","description":"Mobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.","timeFrame":"Change from Baseline RMI at 8 weeks"},{"measure":"Change in Rivermead mobility index (RMI) at 1 month","description":"Mobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.","timeFrame":"Change from Baseline RMI at 1 month"},{"measure":"Change in Rivermead mobility index (RMI) at 3 months","description":"Mobility scale used in neurological rehabilitation. All items are rated in a yes/no format with positive responses scoring a 1 for a maximal RMI score of 15 (15 is better). Changes are evaluated every two weeks for a total of 8 weeks (every 10 sessions of HBOT), than after 1 and 3 months.","timeFrame":"Change from Baseline RMI at 3 months"}],"secondaryOutcomes":[{"measure":"Tympanic damage","description":"Digital photography before and after each daily HBOT session, that means before and after each compression/decompression in the hyperbaric chamber, to detect any ear lesion.","timeFrame":"From date of Start of HBOT until the date of End of HBOT"},{"measure":"Change in Visual Acuity","description":"Snellen chart. Visual acuity test from a distance of 6m. 1 is normal vision, 0 is blindness. Each eye is assessed.","timeFrame":"Change from Baseline Visual Acuity at 3 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with ischemic cortical stroke in chronic stage (â‰¥ 3 months) with residual motor deficits confirmed by imaging with brain CT scan and/or brain MRI\n\nInformed consent\n\nExclusion Criteria:\n\n* Neurological issue:\n\n  * inability to understand the informed consent form\n  * Hemiplegia\n* Hyperbaric issue:\n\n  * Claustrophobia\n  * inability to put on face mask\n  * uncontrolled epilepsy\n  * dementia or psychological disturbance\n  * previous pneumothorax\n  * pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Marco Gelsomino, med pract","affiliation":"Druckkammerzentrum Basel","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Druckkammerzentrum Basel","city":"Basel","zip":"4057","country":"Switzerland","geoPoint":{"lat":47.55839,"lon":7.57327}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T1303","name":"Chronic Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}